Ocera Therapeutics
contact us
home
about us
pipeline
therapeutic areas
clinical trials
partnering and licensing
news and events
Overview
Senior Management Team
Board of Directors
Scientific Advisors
Investors
About Us
Investors
Since its inception in 2005, the company has raised a total of $62 million from premiere life science investors, including Domain Associates, L.L.C., Thomas McNerney & Partners, Sofinnova Ventures and Montagu Newhall Associates.